The responsibility for ensuring the safety of Fildena use primarily lies with the manufacturer, healthcare providers, and patients. The manufacturer is responsible for conducting clinical trials and providing accurate information about the drug, including potential side effects, warnings, and instructions for use. Healthcare providers must assess whether Fildena is suitable for a patient, considering factors such as underlying health conditions, other medications, and individual risk factors.

They are also responsible for monitoring the patient’s response to the drug and adjusting treatment as necessary. Patients themselves must follow prescribed guidelines and report any adverse effects to their healthcare provider. Ultimately, a collaborative approach between all parties is essential to ensure the safe use of Fildena.